Ophthalmology · Queensbury, NY
NPI
1366488025
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
535 Bay Rd, #1
Queensbury, NY, 12804
Phone (518) 793-0331
Groups this clinician bills Medicare through
Medicare paid, 2024
$238K
3,222 services
Medicare patients, 2024
1,155
Average age 78
Drug cost, 2024
$471K
2,233 prescriptions
Company payments, 2025
$1,110
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark H Hite was code 92014 (ophthalmological e&m), 1,055 times for 917 patients. In total Mark H Hite billed 3,222 services in 28 codes, and Medicare paid $238K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-01-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92014 Ophthalmological E&M | Office | 1,055 | 917 | $74.92 | $79K |
| 92134 Computerized Ophthalmic Imaging | Office | 370 | 291 | $24.71 | $9,144 |
| 92012 Ophthalmological E&M | Office | 257 | 209 | $51.82 | $13K |
| 92133 Computerized Ophthalmic Imaging | Office | 247 | 231 | $21.38 | $5,281 |
| 83861 Clinical Chemistry | Office | 230 | 106 | $22.03 | $5,067 |
| 99213 Office E&M - Established | Office | 173 | 116 | $61.45 | $11K |
| 92083 Vision, Hearing, and Speech Services | Office | 151 | 149 | $39.99 | $6,039 |
| 76519 Ultrasound - Nonspecific | Office | 150 | 111 | $35.92 | $5,389 |
| 66984 Cataract Surgery | Facility | 149 | 94 | $396.03 | $59K |
| 92004 Ophthalmological E&M | Office | 128 | 128 | $80.17 | $10K |
| 92250 Angiography | Office | 111 | 106 | $21.42 | $2,377 |
| 66821 Cataract Surgery | Facility | 95 | 69 | $234.49 | $22K |
| 76514 Ultrasound - Nonspecific | Office | 35 | 35 | $6.24 | $219 |
| 65855 Fluid Flow and Drainage of Eye (Any Method) | Facility | 18 | 12 | $148.94 | $2,681 |
By year: 2022 $266K for 3,260 services; 2023 $258K for 3,425 services; 2024 $238K for 3,222 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83861 Clinical Chemistry | 230 | 106 | $22.03 | $5,067 |
Medicare prescription drug claims, 2024
In 2024, the drug Mark H Hite prescribed most often to Medicare patients was Latanoprost, with 771 prescriptions and refills. In total Mark H Hite wrote 2,233 Medicare prescriptions that cost $471K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 771 | 1,802 | 220 | $11K |
| Timolol Maleate Generic | 224 | 528 | 69 | $3,742 |
| Prednisolone Acetate Generic | 157 | 254 | 113 | $5,798 |
| Lumigan Bimatoprost | 157 | 403 | 44 | $104K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 132 | 306 | 38 | $2,288 |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 99 | 213 | 30 | $18K |
| Brimonidine Tartrate Generic | 68 | 156 | 23 | $1,807 |
| Cyclosporine Generic | 56 | 140 | 29 | $31K |
| Erythromycin Erythromycin Base | 50 | 50 | 40 | $567 |
| Restasis Cyclosporine | 50 | 120 | 25 | $73K |
| Combigan Brimonidine Tartrate/Timolol | 41 | 88 | 15 | $21K |
| Ofloxacin Generic | 40 | 41 | 29 | $443 |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 34 | 37 | 30 | $1,419 |
| Doxycycline Hyclate Generic | 33 | 33 | 28 | $284 |
| Simbrinza Brinzolamide/Brimonidine Tart | 32 | 67 | Under 11 | $11K |
Brand drugs: 733 claims; generic drugs: 1,500 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark H Hite $1,110 ($1,110 in general payments such as food, travel and fees) from 10 companies. The largest payer was Abbvie Inc. with $308.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 13 | $308 |
| Alcon Vision LLC ALC | 11 | $208 |
| Dompe US, Inc. | 5 | $144 |
| Astellas Pharma US Inc 4503.T | 2 | $141 |
| Biotissue Holdings Inc. | 3 | $101 |
| Bausch & Lomb Americas Inc. BLCO | 4 | $87.06 |
| Tarsus Pharmaceuticals, Inc. TARS | 3 | $65.71 |
| Ocular Therapeutix, Inc. OCUL | 1 | $19.14 |
| Oyster Point Pharma, Inc. | 1 | $18.3 |
| Sight Sciences, Inc. SGHT | 1 | $17.16 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.